title: Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteins.
abstract: We have analyzed the influence of plasma lipoproteins on the activation of the contact pathway of blood coagulation in platelet-rich plasma (PRP). The formation of thrombin in PRP incubated in vitro was abolished by the factor XIIa antagonist corn trypsin inhibitor and by severe factor XII deficiency, indicating mediation by the contact system. Addition of VLDL to the PRP shortened the lag period and increased the generation of thrombin. There was no effect of HDL and LDL. In whole blood, VLDL accelerated the rate of fibrin formation, the procoagulant effect being prevented by factor XII deficiency and by corn trypsin inhibitor. The thrombin formation in the PRP was strongly increased by microemulsions of the VLDL lipids while it was reduced by the aqueous phase of the particles. Separation of the VLDL lipids indicated the phospholipid component as the major activating principle. Vesicles supplemented with all VLDL phospholipids but lacking specifically the fraction containing phosphatidylethanolamine (PE) prolonged the lag time. The PE containing fraction alone as well as vesicles enriched with egg PE shortened the lag period. In summary, VLDL stimulates the contact pathway of blood coagulation, ethanolamine phospholipids being the most active components of the particles.
authors.affiliation: Physiologisches Institut der Universität München, Universität München, München, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Klein
authors.forename: M
authors.initials: M
authors.lastname: Spannagl
authors.forename: B
authors.initials: B
authors.lastname: Engelmann
mesh_terms: D000328:Adult; D001777:Blood Coagulation; D001792:Blood Platelets / Q000502:physiology; D003324:Coronary Artery Disease / Q000209:etiology; D015956:Factor XIIa / Q000037:antagonists & inhibitors; D006801:Humans; D008079:Lipoproteins, VLDL / Q000737:chemistry / Q000494:pharmacology*; D010714:Phosphatidylethanolamines / Q000502:physiology*; D010743:Phospholipids / Q000032:analysis; D010940:Plant Proteins / Q000494:pharmacology; D013917:Thrombin / Q000096:biosynthesis
chemical_list: D008079:Lipoproteins, VLDL; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D010940:Plant Proteins; C052160:trypsin inhibitor, Zea mays; D015956:Factor XIIa; D013917:Thrombin